🇺🇸 FDA
Patent

US 10441590

Methods for treating pulmonary hypertension

granted A61KA61K31/538A61P

Quick answer

US patent 10441590 (Methods for treating pulmonary hypertension) held by REVIVA PHARMACEUTICALS, INC. expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REVIVA PHARMACEUTICALS, INC.
Grant date
Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/538, A61P, A61P25/22, A61P25/24